Advertisement First Application of Haselmeier's Axis-D Injection Pen in Launched - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Whitepapers

First Application of Haselmeier’s Axis-D Injection Pen in Launched

Haselmeier has announced that the first application of its Axis-D pen platform has been launched.

Commissioned by its client Merck Serono, a division of Merck, Germany, the new injection device has been designed to allow self-injection by patients of a ready to use biopharmaceutical solution for injection.

Download to find out more.

Download whitepaper

Enter your details to get your free whitepaper:


Submit

I have read and accept the terms and conditions and privacy policy.

receive-email We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.

third-party If you would like to hear from carefully selected third party companies, check this box.

company-follow Follow this company to receive notifications when they update.


More from Haselmeier